The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | ALTG ALTA EQUIPMENT GROUP INC. | Mill Road Capital III, L.P. owner | XIn-the-money exercise Put options (obligation to buy)derivative | -62 | $0.00 | $0 | 316 | May 31, 2024 |
| May 29, 2024 | DM Desktop Metal, Inc. | Farhad Fred Ebrahimi owner | XIn-the-money exercise Common Stockindirect: By Farhad F Ebrahimi Roth IRA | +6,200 | $1.50 | $9,300 | 1,216,500 | May 31, 2024 |
| May 29, 2024 | DM Desktop Metal, Inc. | Farhad Fred Ebrahimi owner | XIn-the-money exercise PUT Option (Obligation to Buy)derivativeindirect: By Farhad F Ebrahimi Roth IRA | -6,200 | $0.00 | $0 | 293,800 | May 31, 2024 |
| Apr 25, 2024 | PROP Prairie Operating Co. | Jonathan H. Gray director | XIn-the-money exercise Common Stockindirect: Held by First Idea Ventures LLC | +150,000 | $6.00 | $900k | 230,159 | May 30, 2024 |
| Apr 25, 2024 | PROP Prairie Operating Co. | Jonathan H. Gray director | XIn-the-money exercise Common Stockindirect: Held by First Idea International, Ltd. | +50,975 | $6.00 | $306k | 159,999 | May 30, 2024 |
| Apr 25, 2024 | PROP Prairie Operating Co. | Jonathan H. Gray director | XIn-the-money exercise B Common Stock Purchase Warrantderivativeindirect: Held by First Idea Ventures LLC | -150,000 | $0.00 | $0 | 0 | May 30, 2024 |
| Apr 25, 2024 | PROP Prairie Operating Co. | Jonathan H. Gray director | XIn-the-money exercise B Common Stock Purchase Warrantderivativeindirect: Held by First Idea International, Ltd. | -50,975 | $0.00 | $0 | 0 | May 30, 2024 |
| May 28, 2024 | NSPR InspireMD, Inc. | Gary S Roubin director | XIn-the-money exercise Common Stock | +30,625 | $1.38 | $42k | 501,788 | May 30, 2024 |
| May 28, 2024 | NSPR InspireMD, Inc. | Gary S Roubin director | XIn-the-money exercise Series H Warrant (right to buy)derivative | -30,625 | $0.00 | $0 | 0 | May 30, 2024 |
| May 28, 2024 | MNPR Monopar Therapeutics | Chandler Robinson Chief Executive Officer | XIn-the-money exercise Common Stock | +84,000 | $0.00 | $84 | 250,131 | May 30, 2024 |
| May 28, 2024 | MNPR Monopar Therapeutics | Chandler Robinson Chief Executive Officer | XIn-the-money exercise Stock Optionsderivative | -84,000 | $0.00 | $0 | 0 | May 30, 2024 |
| May 21, 2024 | SLNO SOLENO THERAPEUTICS INC | Ernest Mario director | XIn-the-money exercise Common Stock | +62,000 | $4.50 | $279k | 186,566 | May 23, 2024 |
| May 21, 2024 | SLNO SOLENO THERAPEUTICS INC | Ernest Mario director | XIn-the-money exercise Warrant (right to buy)derivative | -62,000 | $0.00 | $0 | 0 | May 23, 2024 |
| May 20, 2024 | OXY OCCIDENTAL PETROLEUM CORP /DE/ | Carlos M Gutierrez director | XIn-the-money exercise Common Stock | +7,207 | $22.00 | $159k | 65,740 | May 21, 2024 |
| May 20, 2024 | OXY OCCIDENTAL PETROLEUM CORP /DE/ | Carlos M Gutierrez director | XIn-the-money exercise Warrants (Right to buy)derivative | -7,207 | $0.00 | $0 | 0 | May 21, 2024 |
| May 17, 2024 | DM Desktop Metal, Inc. | Farhad Fred Ebrahimi owner | XIn-the-money exercise Common Stockindirect: By Crescent River LLC | +2,059,600 | $1.00 | $2.1M | 26,561,354 | May 20, 2024 |
| May 17, 2024 | DM Desktop Metal, Inc. | Farhad Fred Ebrahimi owner | XIn-the-money exercise PUT Option (Obligation to Buy)derivativeindirect: By Crescent River LLC | -1,719,600 | $0.00 | $0 | 340,000 | May 20, 2024 |
| May 17, 2024 | DM Desktop Metal, Inc. | Farhad Fred Ebrahimi owner | XIn-the-money exercise PUT Option (Obligation to Buy)derivativeindirect: By Crescent River LLC | -340,000 | $0.00 | $0 | 0 | May 20, 2024 |
| May 15, 2024 | HLSQ BiomX Inc. | OrbiMed Israel BioFund GP Limited Partnership owner | XIn-the-money exercise Common Stockindirect: See footnotes | +9,280,408 | $0.24 | $2.3M | 13,797,997 | May 20, 2024 |
| May 15, 2024 | HLSQ BiomX Inc. | OrbiMed Israel BioFund GP Limited Partnership owner | XIn-the-money exercise Warrants (Right to Buy)derivativeindirect: See footnotes | -9,280,408 | $0.00 | $0 | 0 | May 20, 2024 |
| May 15, 2024 | HLSQ BiomX Inc. | Cystic Fibrosis Foundation owner | XIn-the-money exercise Common Stock, par value $0.0001 per share | +4,778,265 | $0.00 | $4,778 | 9,330,580 | May 17, 2024 |
| May 15, 2024 | HLSQ BiomX Inc. | Cystic Fibrosis Foundation owner | XIn-the-money exercise Warrant to purchase common stockderivative | -4,778,265 | $0.00 | $0 | 0 | May 17, 2024 |
| Apr 18, 2024 | DCTH DELCATH SYSTEMS, INC. | Gil Aharon director | XIn-the-money exercise Common Sharesindirect: By Rosalind Advisors Inc., the advisor to the Rosalind Master Funds | +619,946 | $0.01 | $6,199 | 2,681,271 | May 16, 2024 |
| Apr 18, 2024 | DCTH DELCATH SYSTEMS, INC. | Gil Aharon director | XIn-the-money exercise Common Sharesindirect: By Rosalind Advisors Inc., the advisor to the Rosalind Master Funds | +619,946 | $6,199.46 | $3.8B | 2,681,271 | May 16, 2024 |
| Apr 18, 2024 | DCTH DELCATH SYSTEMS, INC. | Steven A J Salamon director | XIn-the-money exercise Common Sharesindirect: By Rosalind Advisors Inc., the advisor to the Rosalind Master Funds | +619,946 | $0.01 | $6,199 | 2,732,586 | May 16, 2024 |
| Apr 18, 2024 | DCTH DELCATH SYSTEMS, INC. | Steven A J Salamon director | XIn-the-money exercise Common Sharesindirect: By Rosalind Advisors Inc., the advisor to the Rosalind Master Funds | +619,946 | $6,199.46 | $3.8B | 2,732,586 | May 16, 2024 |
| Apr 18, 2024 | DCTH DELCATH SYSTEMS, INC. | Rosalind Advisors, Inc. director | XIn-the-money exercise Common Sharesindirect: By Rosalind Advisors Inc., the advisor to the Rosalind Master Funds | +619,946 | $0.01 | $6,199 | 2,763,468 | May 16, 2024 |
| Apr 18, 2024 | DCTH DELCATH SYSTEMS, INC. | Rosalind Advisors, Inc. director | XIn-the-money exercise Common Sharesindirect: By Rosalind Advisors Inc., the advisor to the Rosalind Master Funds | +619,946 | $6,199.46 | $3.8B | 2,763,468 | May 16, 2024 |
| May 14, 2024 | IFN INDIA FUND, INC. | Alan R Goodson director | XIn-the-money exercise Common Stock | +349 | - | - | 1,396 | May 16, 2024 |
| May 14, 2024 | IFN INDIA FUND, INC. | Alan R Goodson director | XIn-the-money exercise Transferable Subscription Right (right to buy)derivative | -1,047 | - | - | 0 | May 16, 2024 |
| May 14, 2024 | IFN INDIA FUND, INC. | Luis F Rubio director | XIn-the-money exercise Common Stock | +333 | - | - | 1,333 | May 16, 2024 |
| May 14, 2024 | IFN INDIA FUND, INC. | Luis F Rubio director | XIn-the-money exercise Transferable Subscription Right (right to buy)derivative | -1,000 | - | - | 0 | May 16, 2024 |
| May 14, 2024 | IFN INDIA FUND, INC. | Nancy Yao director | XIn-the-money exercise Common Stock | +435 | - | - | 1,741 | May 16, 2024 |
| May 14, 2024 | IFN INDIA FUND, INC. | Nancy Yao director | XIn-the-money exercise Transferable Subscription Right (right to buy)derivative | -1,306 | - | - | 0 | May 16, 2024 |
| May 13, 2024 | DM Desktop Metal, Inc. | Farhad Fred Ebrahimi owner | XIn-the-money exercise Common Stockindirect: By Crescent River LLC | +184,500 | $2.00 | $369k | 24,501,754 | May 14, 2024 |
| May 13, 2024 | DM Desktop Metal, Inc. | Farhad Fred Ebrahimi owner | XIn-the-money exercise PUT Option (Obligation to Buy)derivativeindirect: By Crescent River LLC | -184,500 | $0.00 | $0 | 5,977,200 | May 14, 2024 |
| May 12, 2024 | LAWIL Light & Wonder, Inc. | Vanja Kalabic SVP & Chief Accounting Officer | XIn-the-money exercise Common Stock | +938 | $0.00 | $0 | 4,641 | May 14, 2024 |
| May 13, 2024 | LAWIL Light & Wonder, Inc. | Vanja Kalabic SVP & Chief Accounting Officer | XIn-the-money exercise Common Stock | +526 | $0.00 | $0 | 4,816 | May 14, 2024 |
| May 12, 2024 | LAWIL Light & Wonder, Inc. | Vanja Kalabic SVP & Chief Accounting Officer | XIn-the-money exercise Restricted Stock Unitsderivative | -938 | $0.00 | $0 | 0 | May 14, 2024 |
| May 13, 2024 | LAWIL Light & Wonder, Inc. | Vanja Kalabic SVP & Chief Accounting Officer | XIn-the-money exercise Restricted Stock Unitsderivative | -526 | $0.00 | $0 | 526 | May 14, 2024 |
| May 8, 2024 | TRTX TPG RE Finance Trust, Inc. | Starwood Capital Group Global Ii, L.p. owner | XIn-the-money exercise Common Stock | +12,000,000 | $6.89 | $83M | 12,000,000 | May 10, 2024 |
| May 8, 2024 | TRTX TPG RE Finance Trust, Inc. | Starwood Capital Group Global Ii, L.p. owner | XIn-the-money exercise Warrants (right to buy)derivative | -12,000,000 | $0.00 | $0 | 0 | May 10, 2024 |
| May 8, 2024 | TRTX TPG RE Finance Trust, Inc. | PE Holder, L.L.C. owner | XIn-the-money exercise Common Stock | +12,000,000 | $6.89 | $83M | 12,000,000 | May 10, 2024 |
| May 8, 2024 | TRTX TPG RE Finance Trust, Inc. | PE Holder, L.L.C. owner | XIn-the-money exercise Warrants (right to buy)derivative | -12,000,000 | $0.00 | $0 | 0 | May 10, 2024 |
| Apr 29, 2024 | KVYO Klaviyo, Inc. | Shopify Strategic Holdings 3 LLC owner | XIn-the-money exercise Warrants to Purchase Series B Common Stock (Right to Buy)derivative | -344,381 | $0.00 | $0 | 4,476,969 | Apr 30, 2024 |
| Apr 29, 2024 | KVYO Klaviyo, Inc. | Shopify Strategic Holdings 3 LLC owner | XIn-the-money exercise Series B Common Stockderivative | +344,381 | $0.01 | $3,444 | 14,218,051 | Apr 30, 2024 |
| Apr 25, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | James N Topper director | XIn-the-money exercise Common Stockindirect: By: Frazier Life Sciences VIII, L.P. | +1,200,000 | $0.00 | $1,200 | 2,829,366 | Apr 29, 2024 |
| Apr 25, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | James N Topper director | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: By: Frazier Life Sciences VIII, L.P. | -1,200,000 | $0.00 | $0 | 0 | Apr 29, 2024 |
| Apr 22, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | Brightstar Associates LLC owner | XIn-the-money exercise Common Stock | +48,136 | $0.01 | $481 | 23,107,844 | Apr 24, 2024 |
| Apr 22, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | Brightstar Associates LLC owner | XIn-the-money exercise Warrants (right to buy)derivative | -48,136 | $0.00 | $0 | 0 | Apr 24, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.